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EDITORIAL
A new partnership between TGF-1 and glucocorticoids in the
network of inflammation
The past decades have seen the discovery of a myriad of coids have been shown to down-regulate activity of nu-
pro- and anti-inflammatory molecules. Interleukins (IL), clear factor-kappa B (NF-B) in various models of
chemokines, glucocorticoids, and the transforming growth glomerulonephritis. They ameliorate local inflammation
factor beta (TGF-) superfamily, to name a few, all partic- and facilitate apoptosis in mesangial cells. The numerous
ipate in the process of inflammation. Moreover, it has effects of glucocorticoids are mediated through interaction
become quite obvious that the behavior of these molecules of their corresponding glucocorticoid receptors with the
tends to act beyond cliches of black and white. Many nucleus.
of the so-called proinflammatory mediators exert under Glucocorticoids and the TGF- family interact in many
certain circumstances anti-inflammatory effects or play a different ways. In human T lymphocytes glucocorticoids
role in the resolution of inflammation and vice versa. Thus, increase the expression of TGF-1 by up-regulation of
regulation of the homeostasis of inflammation is complex transcription [3]. In human osteoblast-like cells, steroids
and depends on a wide range of regulatory loops. A large augment the levels of functional TGF- by facilitating the
array of molecules regulate each other, and the effect on cleavage of the latency associated peptide [4]. In another
the inflammatory process varies, depending on the model system, however, glucocorticoids down-regulate TGF-1
and the time course of inflammation. and 2 expression in lung fibroblasts, by the interception
In this issue of Kidney International, Baud et al [1] of an intrinsic positive feedback control mechanism for
describe a new and intriguing mechanism of interaction TGF- [5]. A synergy of glucocorticoids and TGF-1 ex-
between TGF-1 and glucocorticoids in a model of human ists, however, in fibrotic tissue remodeling [6]. These ex-
macrophages. Their data add to the complexity of the amples emphasize the complexity and the importance of
process of inflammation and its resolution, but also make interactions between glucocorticoids and TGF- in differ-
it more interesting. ent cell types and even in more complex pathophysiologic
Since its discovery approximately 20 years ago, the situations.
TGF- family of polypeptides has undergone extensive Baud et al [1] demonstrate in this issue of Kidney Inter-
studies. To date, five different members are identified national a new direct effect of TGF-1 on glucocorticoid
in vertebrates. Three members (TGF-1, 2, and 3) are binding and signaling in human U 937 cells. They show
expressed in mammals. TGF- inhibits growth of many very convincingly that the exposure of U 937 cells to
hematopoetic and epithelial cells and plays a major role TGF-1 increases dexamethasone specific binding, which
in the production of extracellular matrix. TGF-s exert is due to an increase of binding sites. The signal transduc-
pivotal effects on developmental processes, cell cycle regu- tion cascade of the TGF- superfamily has the shape of
lation, and acute and chronic inflammation. Increased an hour glass. Signaling is mediated through a tetrameric
TGF- formation has been reported and linked to the receptor complex, consisting of two heterodimers of one
production of extracellular matrix in a large number of of seven different type I and one of five type II transmem-
different animal models and human renal diseases. Vari- brane proteins. Receptor Smad proteins (Smad1 to Smad3,
ous stimuli such as angiotensin II, thromboxane A2, reac- Smad5, and Smad8) are then activated via phosphoryla-
tive oxygen species and high glucose are known to regulate tion by the type I receptor subunit and accumulate in
collagen formation in renal tissue due to effects on TGF-. the nucleus after association with the Co-Smad protein
Therefore, TGF- is a central player in initiation and (Smad4). Here this heteromeric complex can interact
resolution of renal inflammation [2]. Another family of with a wide range of DNA-binding proteins, such as
hormones with an even wider range of effects are the activator protein-1 (AP-1), stimulatory protein-1 (SP-1)
glucocorticoids. One very well-known and therapeutically and many others, to regulate transcription of a multitude
widely used effect of glucocorticoids is the control of tran- of genes. A great number of interactions between the
scription of pro- and anti-inflammatory genes. Glucocorti- TGF- pathway and that of other signal cascades as well
as Smad-independent pathways have been reported [7].
Baud et al [1] now demonstrate that both Smad2 andKey words: transforming growth factor-, glucocorticoids, inflammation,
Smad, AP-1. Smad3 are involved in the TGF-1–mediated up regula-
tion of glucocorticoid binding. The Smads are shown to 2003 by the International Society of Nephrology
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